Article Text

Download PDFPDF
CASE REPORT
Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis type 1: a case with review of the literature
  1. Subhanudh Thavaraputta1,
  2. Suzanne Graham2,
  3. Ana M Rivas Mejia3 and
  4. Joaquin Lado-Abeal3
  1. 1 Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
  2. 2 Department of Pathology, Texas Tech Univeristy Health Sciences Center, Lubbock, Texas, USA
  3. 3 Division of Endocrinology, Department of Internal Medicine, Texas Tech University Health Science Center School of Medicine, Lubbock, Texas, USA
  1. Correspondence to Dr Ana M Rivas Mejia, marcella.rivas{at}ttuhsc.edu

Abstract

Somatostatinomas are rare neuroendocrine tumours, mostly located in the pancreas or duodenum, with an estimated incidence of 1 in 40 million. Duodenal somatostatinomas (DSs) are usually found in association with neurofibromatosis type 1 (NF1), tuberous sclerosis and Von Hippel-Lindau syndrome. Gastrointestinal stromal tumours (GIST) have also been described in NF1, but the association with somatostatinoma is very uncommon. We report the case of a patient with NF1 who presented with obstructive jaundice due to multiple firm nodules around the ampulla of Vater. A pancreaticoduodenectomy was performed and revealed a 1 cm duodenal/ampullary mass which stained positive for somatostatin, together with a GIST also found on the duodenal wall. Despite its rarity, ampullary somatostatinomas should be considered in the differential diagnosis of biliary tract dilation in patients with NF1.

  • endocrine cancer
  • neuro genetics
  • neuroendocrinology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Obtained.

  • Contributors ST: data acquisition, drafting manuscript, manuscript revision, gathering information, and literature review/search. SG: involved in a patient care, manuscript revision, image selection and interpretation. JL-A: involved in patient care, manuscript revision and final approval. ARM: manuscript revision, data acquisition and corresponding author.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.